{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:54Z","timestamp":1761468894671,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.transci.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:26:05Z","timestamp":1563794765000},"page":"102590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case study: Therapeutic plasma exchange in voltage-gated potassium channel autoimmune encephalitis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-4989","authenticated-orcid":false,"given":"Mohit","family":"Chowdhry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva Prasad","family":"Gajulapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2019.07.003_bib0010","first-page":"65","article-title":"Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations","volume":"5","author":"Rueff","year":"2008","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.transci.2019.07.003_bib0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2010.03.024","article-title":"Management of voltage-gated potassium channel antibody disorders","volume":"28","author":"Merchut","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.transci.2019.07.003_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","article-title":"Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping","volume":"70","author":"Klein","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.transci.2019.07.003_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/AN20120095","article-title":"LGI proteins inthe nervous system","volume":"5","author":"Kegel","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.transci.2019.07.003_bib0030","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/brain\/awl084","article-title":"Neuromyotoniaand limbic encephalitis sera target mature Shaker-typeK1 channels: subunit specificity correlates with clinical manifestations","volume":"129","author":"Kleopa","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.transci.2019.07.003_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/qjmed\/hcn143","article-title":"A treatable form of amnesia and rapid cognitive decline","volume":"102","author":"Ahmad","year":"2009","journal-title":"Q J Med"},{"key":"10.1016\/j.transci.2019.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/0140-6736(91)92623-A","article-title":"Autoimmune aetiology for acquired neuromyotonia","volume":"338","author":"Bady","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2019.07.003_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(91)90073-X","article-title":"Autoimmune aetiology for acquired neuromyotonia (Isaac\u2019ssyndrome)","volume":"338","author":"Sinha","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2019.07.003_bib0050","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019ssyndrome: peripheral and central nervous system and cardiacinvolvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.transci.2019.07.003_bib0055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/jnnp.2003.031401","article-title":"Sub-acute presentation of Morvan\u2019ssyndrome after thymectomy","volume":"75","author":"Cottrell","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.transci.2019.07.003_bib0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004691-200411000-00008","article-title":"Neurophysiologic studies in Morvan syndrome","volume":"21","author":"Josephs","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.transci.2019.07.003_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2019.07.003_bib0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy:a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.transci.2019.07.003_bib0075","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/0140-6736(91)92623-A","article-title":"Autoimmune aetiology for acquired neuromyotonia","volume":"338","author":"Bady","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2019.07.003_bib0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s004150050419","article-title":"Acquired neuromyotonia: superiority of plasma exchangeover high-dose intravenous human immunoglobulin","volume":"246","author":"van den Berg","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.transci.2019.07.003_bib0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ncl.2010.03.024","article-title":"Management of voltage-gated potassium channel antibody disorders","volume":"28","author":"Merchut","year":"2010","journal-title":"Neurol Clin"},{"issue":"November (5)","key":"10.1016\/j.transci.2019.07.003_bib0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jca.21233","article-title":"Plasma exchange as a therapeutic option in patients withneurologic symptoms due to antibodies to voltage-gated potassium channels: areport of five cases and review of the literature","volume":"27","author":"Jaben","year":"2012","journal-title":"J Clin Apher"},{"issue":"February (1)","key":"10.1016\/j.transci.2019.07.003_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jca.21395","article-title":"Therapeuticplasma exchange as a steroid-sparing therapy in a patient with limbicencephalitis due to antibodies to voltage-gated potassium channels","volume":"31","author":"Martin","year":"2016","journal-title":"J Clin Apher"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:50:54Z","timestamp":1761468654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219301211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1473050219301211"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.07.003","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case study: Therapeutic plasma exchange in voltage-gated potassium channel autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102590"}}